White-matter integrity predicts stroop performance in patients with geriatric depression

Biol Psychiatry. 2007 Apr 15;61(8):1007-10. doi: 10.1016/j.biopsych.2006.07.028. Epub 2006 Nov 21.

Abstract

Background: This study tested the hypothesis that microstructural white matter abnormalities in frontostriatal-limbic tracts are associated with poor response inhibition on the Stroop task in depressed elders.

Method: Fifty-one elders with major depression participated in a 12-week escitalopram trial. Diffusion tensor imaging was used to determine fractional anisotropy (FA) in white matter regions. Executive function (response inhibition) was assessed with the Stroop task. Voxelwise correlational analysis was used to examine the relationship between Stroop performance and fractional anisotropy.

Results: Significant associations between FA and Stroop color word interference were evident in multiple frontostriatal-limbic regions, including white matter lateral to the anterior and posterior cingulate cortex and white matter in prefrontal, insular, and parahippocampal regions.

Conclusions: These findings suggest that microstructural white matter abnormalities of frontostriatal-limbic networks are associated with executive dysfunction of late-life depression. This observation provides the rationale for examination of specific frontostriatal-limbic pathways in the pathophysiology of geriatric depression.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anisotropy
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Brain Mapping
  • Citalopram / therapeutic use
  • Depression / drug therapy
  • Depression / pathology
  • Depression / physiopathology*
  • Diffusion Magnetic Resonance Imaging / methods
  • Female
  • Geriatric Assessment*
  • Humans
  • Inhibition, Psychological
  • Male
  • Middle Aged
  • Neural Pathways / drug effects
  • Neural Pathways / pathology
  • Neuropsychological Tests*
  • Predictive Value of Tests
  • Problem Solving / physiology

Substances

  • Antidepressive Agents, Second-Generation
  • Citalopram